Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Cancer, Endocrine, Thyroid Cancer |
| Therapuetic Areas: | Endocrinology, Oncology |
| Healthy: | No |
| Age Range: | 18 - 127 |
| Updated: | 5/9/2018 |
| Start Date: | November 2004 |
| End Date: | April 19, 2017 |
An Open Label, Two Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.
The purpose of this open label, two stage, phase II study is to evaluate the efficacy and
tolerability of ZD6474 in patients with locally advanced or metastatic hereditary medullary
thyroid carcinoma.
tolerability of ZD6474 in patients with locally advanced or metastatic hereditary medullary
thyroid carcinoma.
Inclusion Criteria:
- Locally advanced or hereditary medullary thyroid cancer
- Signed informed consent
- One or more measurable lesions
Exclusion Criteria:
- Brain metastases or spinal cord compression
- Specific laboratory ranges
- Specific heart problems
- Prior chemotherapy and/or radiation therapy
- Participation in other trials within 30 days
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials